Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jessie Myers"'
Autor:
Jordan Gauthier, Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Victor A. Chow, Ajay K. Gopal, Alexandria Hodges Dwinal, Staci Williamson, Jessie Myers, Andy Chen, Sarah Nagle, Brandon Hayes-Lattin, Levanto Schachter, David G. Maloney, Cameron J. Turtle, Mohamed L. Sorror, Richard T. Maziarz
Publikováno v:
Blood
CD19-targeted chimeric antigen receptor-engineered (CD19 CAR) T cells are novel therapies showing great promise for patients with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL). Single-arm studies showed significant varia
Autor:
Galit Perets, Rachel J. Cook, Staci Williamson, Charles Dibb, Jessie Myers, Gabrielle Meyers, Richard T. Maziarz, Luke B Fletcher, Curtis Lachowiez
Publikováno v:
Transplantation and Cellular Therapy. 27:S159-S161
Autor:
Jessie Myers, Eva Medvedova, Staci Williamson, Derek Galligan, Sarah J. Nagle, Andy I. Chen, Richard T. Maziarz, Levanto Schachter, Rebecca Silbermann
Publikováno v:
Transplantation and Cellular Therapy. 27:S414-S416
Autor:
Rachel Cook, Staci Williamson, Jessie Myers, Laura F. Newell, Jennifer N Saultz, Jessica T. Leonard, Brandon Hayes-Lattin, Arpita Gandhi, Levanto Schachter, Andy I. Chen, Jennifer Smith, Mariana Perez Varona Bolanos, Alexandria Hodges Dwinal, Robert Ahrenkiel, LeeAnn Farestrand, Chi Phan, Richard T Maziarz
Publikováno v:
Transplantation and Cellular Therapy. 28:S326-S327
Autor:
Derek Galligan, Staci Williamson, Jessie Myers, Robert Ahrenkiel, Chi Phan, Levanto Schachter, Andy I. Chen, Brandon Hayes-Lattin, Craig Okada, Stephen Spurgeon, Richard T Maziarz
Publikováno v:
Transplantation and Cellular Therapy. 28:S422-S423
Autor:
Nicolas Gazeau, Pere Barba, Gloria Iacoboni, Mi Kwon, Rebeca Bailen, Juan Luis Reguera, Lucía López-Corral, Rafael Hernani, Valentin Ortiz-Maldonado, Antonio Pérez-Martínez, Richard T Maziarz, Staci Williamson, Jessie Myers, Alexandria Hodges Dwinal, Eneida R. Nemecek, Mazyar Shadman, Andrew J. Cowan, Damian J. Green, Victor A. Chow, Alexandre V. Hirayama, David G. Maloney, Cameron J. Turtle, Jordan Gauthier
Publikováno v:
Transplantation and Cellular Therapy. 28:S185-S186
Autor:
Guido Ghilardi, Raymone Pajarillo, Jessie Myers, Simon F. Lacey, Danielle Victoriano, David L. Porter, Ulrich Jaeger, Ellen Napier, Stefan K. Barta, Shannon H. Gier, Philipp Wohlfarth, Stephen J. Schuster, Elizabeth Weber, Sunita D. Nasta, Jakub Svoboda, Hatcher J. Ballard, Elise A. Chong, Marco Ruella, Daniel J. Landsburg, James N. Gerson, Rebecca Yelton, Staci Williamson, Alfred L. Garfall, Richard T. Maziarz
Publikováno v:
Blood. 138:1438-1438
Background . Anti-CD19 chimeric antigen receptor T cells (CART19) are now a standard treatment for patients (pts) with relapsed/refractory (r/r) large B-cell lymphomas (LBCL). Lymphodepleting chemotherapy (LD) is administered before CART19 to optimiz
Autor:
Paula Perkins, Andy I. Chen, Jordan Gauthier, Cameron J. Turtle, Brandon Hayes-Lattin, Levanto Schachter, Jessie Myers, David G. Maloney, Aisling Cearley, Staci Williamson, Mazyar Shadman, Mohamed L. Sorror, Sarah J. Nagle, Angela Kirk, Richard T. Maziarz
Publikováno v:
Journal of Clinical Oncology. 39:7532-7532
7532 Background: CD19-targeted chimeric antigen receptor-engineered (CD19 CAR) T cells achieve high response rates in patients (pts) with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (NHL), but are limited by cytokine release s